
CAS 1242137-15-0
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluorobenzoic Acid
CAS:4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluorobenzoic AcidFormula:C20H13F4N3O3SPurity:98%Molecular weight:451.39Enzalutamide carboxylic acid
CAS:4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluorobenzoic acidFormula:C20H13F4N3O3SPurity:98%Molecular weight:451.39Enzalutamide Carboxylic Acid Metabolite (M1)
CAS:Formula:C20H13F4N3O3SPurity:98%Color and Shape:SolidMolecular weight:451.3941Enzalutamide Carboxylic Acid Metabolite (M1)
CAS:Formula:C20H13F4N3O3SColor and Shape:White To Off-White SolidMolecular weight:451.40Enzalutamide carboxylic acid
CAS:Enzalutamide carboxylic acidFormula:C20H13F4N3O3SPurity:≥95%Molecular weight:451.39Enzalutamide carboxylic acid
CAS:Enzalutamide carboxylic acid is an antagonist of androgen receptor (AR) .Formula:C20H13F4N3O3SPurity:97.88%Color and Shape:SolidMolecular weight:451.39Ref: TM-T8217
1mg63.00€2mg88.00€5mg119.00€1mL*10mM (DMSO)133.00€10mg177.00€25mg299.00€50mg416.00€100mg615.00€Enzalutamide Carboxylic Acid
CAS:Applications Enzalutamide Carboxylic Acid is used as hormone therapies to prevent androgen-fuled growth of castrate-resistant prostate cancer.
References Tomasz, M.B., et al.: New Engl, J. Med., 424, 371 (2014);Formula:C20H13F4N3O3SColor and Shape:NeatMolecular weight:451.39Ref: 10-F843830
1mg98.00€5mg120.00€10mg136.00€25mg148.00€50mg162.00€100mg186.00€250mg294.00€1g609.00€Enzalutamide Carboxylic Acid
CAS:Enzalutamide Carboxylic Acid is a potent n-oxide derivative of Enzalutamide, which is used in the treatment of metastatic castration-resistant prostate cancer. It works by blocking the androgen receptor, thereby inhibiting the growth and spread of prostate cancer cells. Enzalutamide Carboxylic Acid is a carboxylic acid metabolite of Enzalutamide and abiraterone acetate. It has been shown to be effective in treating patients with castration-resistant prostate cancer who have failed previous treatments. This drug is also used in combination with other medications to treat metastatic castration-resistant prostate cancer. Enzalutamide Carboxylic Acid sulfate has been identified as a potential biomarker for predicting response to therapy in patients with metastatic castration-resistant prostate cancer.Formula:C20H13F4N3O3SPurity:Min. 95%Molecular weight:451.39 g/mol








